Resident Company News

Dianomi previously licensed its core technology, the mineral coated microparticles, from WARF, UW-Madison's tech-transfer arm. The new license expands the technology's use to nucleic acid therapy — using DNA or RNA, or related compounds, to modify or enhance the expression of desired genes....

Cancer diagnostics company Exact Sciences Corp. has more than doubled the capital investment and job creation numbers it proposed under an agreement with the Wisconsin Economic Development Corp., according to documents obtained by the Milwaukee Business Journal per a public records request....